Autoimmune Diseases Information for Researchers

NIAID supports a broad range of basic, preclinical, and clinical research in autoimmune diseases. Research is focused on the immunologic basis of disease, including developing a greater understanding of the fundamental immunologic principles underlying disease onset and progression, developing improved animal models of disease, developing improved diagnostic tools, and identifying and evaluating more effective immune-based treatment and prevention strategies.

Through the information offered here, researchers can learn about the science being conducted at NIAID and by NIAID-funded researchers. Researchers seeking funding can access opportunities to further their own research, while NIAID and NIH grantees can find out about available resources outside of specific funding opportunities. Recent publications, active networks, and ways to connect with other researchers are also available.


NIAID encourages partnerships among other agencies and foundations, private industry, federal and local government and other organizations with similar goals to help build and sustain research infrastructure and to translate and implement research findings as public health practices.

Read more about NIAID-supported collaborations and partnerships that further autoimmune disease research

The AMP AIM Program 

NIAID supports the Accelerating Medicines Partnership® Autoimmune and Immune-Mediated Diseases (AMP® AIM) program, which launched in 2021 to deepen understanding of the cellular and molecular interactions that lead to inflammation and autoimmune diseases.

Read more about the AMP AIM Program

Resources for Researchers

NIAID offers resources to advance science from basic research through advanced clinical evaluation, with the goal of developing new and improved products such as diagnostics, vaccines and therapeutics. 

Read more about resources for autoimmune disease researchers
Content last reviewed on